Utah Medical Products
UTMD
59 hedge funds and large institutions have $133M invested in Utah Medical Products in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 7 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 63 → 59 (-4)
10% less capital invested
Capital invested by funds: $147M → $133M (-$14.4M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$875K |
| 2 |
CYG
Clean Yield Group
Norwich,
Vermont
|
+$866K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$857K |
| 4 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$452K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$378K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$2.47M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$631K |
| 3 |
WCM
Wallace Capital Management
Dallas,
Texas
|
-$537K |
| 4 |
M&T Bank
Buffalo,
New York
|
-$444K |
| 5 |
Two Sigma Investments
New York
|
-$226K |
UTMD Hedge Fund Activity: Q3 2015 in Review
59 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2015, worth a combined $133M — down 9.8% from $147M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of UTMD and 3 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 23 added.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $875K. The largest seller was Morgan Dempsey Capital Management, cutting an estimated $2.47M.
- 59 institutional investors held Utah Medical Products (UTMD) as of Q3 2015, down from 63 in Q2 2015.
- Funds reported $133M of Utah Medical Products stock for Q3 2015, down 9.8% quarter-over-quarter.
- 3 funds opened new Utah Medical Products positions in Q3 2015 and 7 closed out, a net change of -4 holders.
- The largest Utah Medical Products buyer in Q3 2015 was JP Morgan Chase, an estimated $875K added.
- The largest Utah Medical Products seller in Q3 2015 was Morgan Dempsey Capital Management, an estimated $2.47M sold.
Based on aggregated 13F filings for Q3 2015.